All authors are required to complete the disclosure process either disclosing all financial relationships with commercial interests or indicating that none exist. The deadline for completing disclosure is Friday, Dec. 23, 2016, at 3 p.m. ET. The deadline for completing disclosure for late-breaking submissions is Wednesday, Feb. 22, 2017, at 3 p.m. ET.
As part of the disclosure process, authors will be asked if they have any relationships with commercial interests. Authors with such relationships will be asked to list the name(s) of the companies with which they are involved, the benefits received (e.g., salary, consulting fee, ownership interest, etc.) and any roles they play within the named commercial entities (e.g., advisory committee member, board member, employee, shareholder, etc.). Authors without relationships may state that they have no information to disclose.
Submitting authors may complete their disclosure at the abstract submission site. Upon submission of an abstract, all co-authors will receive an email message informing them that they have been listed as a co-author of an abstract and that they are required to complete financial disclosure. The message will contain a link co-authors may use to log into the abstract submission site to complete the disclosure form.
It is the submitting author’s responsibility to ensure that all co-authors submit their financial disclosure for DDW 2017. Abstracts missing co-author financial disclosures will be in jeopardy of not being reviewed and involuntarily withdrawn from DDW 2017. Submitting authors are not permitted to submit a disclosure on a co-author’s behalf.